|
As of March 7, 2008, we had 29.96 million shares of common stock outstanding and 37.09 million on a fully diluted basis.
more
|
|
As of September 30, 2008 Raptor Pharmaceuticals Corp. had 60.3 million shares of common stock and zero shares of preferred stock outstanding.
more
|
|
Rigel had approximately 36.7 million common shares outstanding as of March 31, 2009. 8.
more
|
|
As of June 30, 2007, Pareto had 44,726,875 common shares outstanding.
|
|
Rigel had approximately 36.6 million common shares outstanding as of December 31, 2008. 8.
more
|
|
As of November 30, 2008 Raptor Pharmaceuticals Corp. had 60.4 million shares of common stock and zero shares of preferred stock outstanding.
more
|
|
As at June 30, 2007, there were approximately 38.9 million units outstanding, including exchangeables.
|
|
As of June September 30, 2008, there were 86.5 million diluted shares of common stock outstanding.
more
|
How many shares are outstanding?
Related Questions
- Price quotes on the most liquid and recent issues are shown by professional bond market participants on ...
- The Outstanding Scholar Program was established as a supplement to the competitive examining process. This ...
- Our shares outstanding can be found on Google Finance.
- Your account is currently in a Margin Call which generally needs to be satisfied (or covered) immediately, ...
- The National Association of Homebuilders (NAHB) named BioBased 501 the "Outstanding Green Product of the Year" ...